Thai elderly people with the minimum age of 55 years in the elderly center or the Center of the Development of Quality of Life for the Elderly who were not diagnosed with dementia or mild cognitive impairment (MCI)
- Population to be studied
Thai elderly people with the minimum age of 55 years in the elderly center or the Center of the Development of Quality of Life for the Elderly who were literate and not diagnosed with dementia or MCI and participate in activities held by the elderly center.
Thai elderly people with the minimum age of 55 years who joined activities at the elderly center showed interest and willingness in being part of the study. Criteria for sample selection are as follows.
1. Those who are ≥ 55 years old.
2. Those who are members of the elderly center/ club.
3. Those who show a willingness to participate in the study.
1. Those whose education level is lower than six years of education.
2. Those who have a visual disorder cannot see with glasses on.
3. Those who even with hearing aids have hearing difficulties that impair their communication.
4. Those who have been a member of the elderly center/ club for shorter than three months.
5. Those who have compromised intellect and possess the Thai Mental Status Examination (TMSE)8 score of < 24.
6. Those who are diagnosed with dementia based on DSM-54 and the National Institute on Aging5 and have Clinical Dementia Rating Scale (CDR) ≥ 1.
7. Those who are diagnosed with MCI based on DSM-54 and the National Institute on Aging7 and have Clinical Dementia Rating Scale (CDR) of 0.5.
8. Those who are currently diagnosed with all substance use disorders except tobacco and caffeine use disorder based on DSM-5.
9. Those who are diagnosed with neurological disorders are stroke, epilepsy, and Parkinson’s disease.
10. Those who are diagnosed with major psychiatric disorders, for instance, psychotic disorders, bipolar disorders, and major depressive disorders are based on DSM-5.
11. Those who use benzodiazepine every day
12. Those who use anticholinergics every day
13. Those who use Acetylcholinesterase inhibitor (AChEI) every day.
14. Those who use N-methyl D-aspartate (NMDA) receptor antagonists every day.
Eligible participants were recruited at the Senior Society of Nonthaburi Municipality, Bangkok, Thailand due to its following qualities:
1. It was a place established to improve the quality of life and promote the career of the Thai elderly.
2. It was located in the area of Bangkok Metropolitan or its vicinity.
3. It had approximately 200 members who were at least sixty years old. This number was sufficient for the volunteer recruitment in this study. (Based on the participation rate at 50%)
4. It had an activity room that could accommodate at least 50 people.
The sample size was estimated using a 1:1 ratio 2–sample parallel RCT with a continuous outcome.
The statistical significance level of α = 0.05
The power (β) was set at 0.80
When values were substituted in the formula, μ_con, the mean of TMSE in normal elderlies obtained from the literature review, was 27.80 and σ was 1.57.
The effect size was set at 1.0 (difference of the mean of TMSE between the treatment and control group). According to this formula, the number of each arm was 39; however, the author prevented the loss of follow-ups on the participants by increasing the sample size by 10 percent. As a result, the final sample size per arm was 44.
1. Materials for primary outcome
The primary outcome was the evaluation of global cognitive function with the use of the Thai Mental Status Examination (TMSE), of which total score is 30 and is divided into six categories: orientation (score of 6), registration (3), attention (5), calculation (3), language (10), and recall (3). The average total score among Thai elderlies (60-70 years old) who are free from underlying diseases and psychoactive substances is 27.38±2.02. According to this examination, elderlies who scored higher than 23 were considered normal.
2. Materials for secondary outcome
The secondary outcome consisted of three components:
2.1 Evaluation of cognitive function was performed in merely five from the total of six subdomains by using a neuropsychological assessment battery.
- Attention-concentration with Digit Span Forward
- Working memory with Digit Span Backward
- Secondary verbal memory with Word List Learning in Alzheimer’s Disease Assessment Scale — cognitive subscale (ADAS-cog)13
- Psychomotor speed with Trail-Making Test A
- Executive function with Trail-Making Test B
- Delayed recall memory with Word Recall in Alzheimer’s Disease Assessment Scale — cognitive subscale (ADAS-cog)13
- Visuoconstructional-perceptional ability with Constructional praxis in Alzheimer’s Disease Assessment Scale — cognitive subscale (ADAS-cog)
- Language fluency with Letter and Category Fluency Test
2.2 Assessment of Elderlies’ Quality of Life was composed of
- Thai Geriatric Depression Scale-15 (TGDS-15)
- Older People's Quality of Life Questionnaire (OPQOL-Brief)
- Identification of the Study End Point
This project lasted 24 weeks (6 months) with two points of time when the outcome was investigated.
1. In the 12th week of the study, when the participants in the control group received their last CTs, both primary and secondary outcomes were measured to point out their immediate effect.
2. In the 24th week when the participants in the treatment group received their last CT, both primary and secondary outcomes are examined to see it sustain effect of CT. However, between the 12th and the 24th week, no CTs were arranged.
1. Data analysis with descriptive statistics was implemented to analyze the participants’ personal data, which were frequency and percent. In case the data showed normal distribution, mean, standard deviation (SD), 95% confidence interval (95% CI) were applied; whereas when the data were irregularly distributed, median and interquartile range (IQR) were used instead.
2. Comparative analysis of primary outcome and secondary outcome in the treatment and control group was carried out using an independent sample t-test because the study aimed to measure the resulting mean of the cognitive function of the two groups: the treatment group who received CT and the wait-list control group.
3. The comparison between the primary and secondary results was performed twice, in the third and sixth month, to examine the treatment effect (immediate effect) and carryover effect (sustained effect) respectively.
4. When some participants terminated their participation or missed their follow-ups or appointments, Intention- To-Treat (ITT) analysis was carried out in comparison with Per-Protocol analysis (PP) based on the data of all participants who passed the screening and were selected as the control group regardless of their study protocol completion.